SMN1 and spinal muscular atrophy: The first approach is used in the therapy of spinal muscular atrophy (SMA), autosomal recessive disorder in 95% of cases caused by homozygous deletion of exon 7 of the SMN1 gene (Jedrzejowska et al. 2010).